Endocannabinoid Modulation Using Monoacylglycerol Lipase Inhibition in Tourette Syndrome: A Phase 1 Randomized, Placebo-Controlled Study.
Kirsten R Muller-VahlCarolin FremerChan BealsJelena IvkovicHenrik LoftChristoph SchindlerPublished in: Pharmacopsychiatry (2021)
In this exploratory trial, a single dose of Lu AG06466 showed statistically significant positive effects on key measures of TS symptoms.